Search Result
Showing 61-63 of 63 results
Roche is a global pi...
Roche is a global pioneer in pharmaceuticals and diagnostics, focused on advancing science to improve people's lives. The combined strength of pharmaceuticals and diagnostics under one roof has made Roche a leader in personalized healthcare – a strat...
Yuyu Pharma (KRX 000...
Yuyu Pharma (KRX 000220) was founded in 1941 and is a healthcare company located in Korea. The company is publicly traded since 1975. It manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in...
ST Pharm is a subsid...
ST Pharm is a subsidiary company of Dong-A Socio Group, Korea’s top pharmaceutical company with a history of 80 years. Since 1983, ST Pharm has been offering excellent custom manufacturing services of oligonucleotides and small molecule APIs to meet...
Roche is a global pioneer in pharmaceuticals and diagnostics, focused on advancing science to improve people's lives. The combined strength of pharmaceuticals and diagnostics under one roof has made Roche a leader in personalized healthcare – a strategy that aims to tailor the right treatment to each patient as best as possible. Roche is the world's largest biotechnology company, with highly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology, and central nervous system diseases. Roche is also a world leader in in vitro diagnostics and tissue-based cancer diagnostics, as well as a leader in diabetes management.
Yuyu Pharma (KRX 000220) was founded in 1941 and is a healthcare company located in Korea. The company is publicly traded since 1975. It manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. The key therapeutic markets are CNS, Osteoporosis, Respiratory, and Urology. The R&D center has previously developed two unique improved medicines, Maxmarvil® for patients with osteoporosis and YUCLID® for anti-thrombosis. Currently, Yuyu Pharma has two new drug discovery programs targeting benign prostatic hyperplasia (BPH) and dry eye syndrome. Yuyu Pharma also has various Over-the-counter drugs and dietary supplements, such as YupanC® (vitamin C), Venoplus® (ointment), and Venapollo® (multivitamins)
ST Pharm is a subsidiary company of Dong-A Socio Group, Korea’s top pharmaceutical company with a history of 80 years. Since 1983, ST Pharm has been offering excellent custom manufacturing services of oligonucleotides and small molecule APIs to meet clients’ high expectation for their use in pharmaceutical development in compliance to cGMP requirements. The expansion of oligonucleotide production capabilities became a new growth engine for the future pharmaceutical industry. In particular, the expansion of Oligonucleotide Plant in 2018 has secured its place as Global Top 3 oligonucleotide manufacturer. Based on the in-depth knowledge from manufacturing nucleoside to oligonucleotide, it has enabled ST Pharm to leverage its know-how into manufacturing polynucleotide, the mRNA. ST Pharm has in-house mRNA platform which enables development and production of mRNA vaccines.
